Transition to endemicity: Understanding COVID-19.

Transition to endemicity: Understanding COVID-19.
复制标题

DOI:
10.1016/j.immuni.2021.09.019
复制
发表时间:
2021-10-12
期刊:
影响因子:
32.4
通讯作者:
Halloran ME
Halloran ME
中科院分区:
医学1区
文献类型:
--
作者:
Antia R;Halloran ME

文献摘要

参考文献

被引文献

相似文献

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 及其相关疾病 2019 年冠状病毒病 (COVID-19) 的出现在全球范围内造成了毁灭性的大流行。在这里,我们解释了从流行病到地方病状态转变的基本概念,其中病原体在人群中稳定存在。我们讨论从流行病阶段过渡到地方病阶段期间感染数量和疾病严重程度如何变化,并考虑这种过渡在 COVID-19 背景下的影响。严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 及其相关疾病 2019 年冠状病毒病 (COVID-19) 的出现在全球范围内造成了毁灭性的大流行。在这里,我们解释了从流行病到地方病状态转变的基本概念,其中病原体在人群中稳定存在。我们讨论从流行病阶段过渡到地方病阶段期间感染数量和疾病严重程度如何变化,并考虑这种过渡在 COVID-19 背景下的影响。
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19.
DOI: 10.1038/s41597-020-00668-y
发表时间: 2020-10-15
期刊: Scientific data
影响因子: 9.8
作者:
Glynn JR;Moss PAH
通讯作者: Moss PAH
DOI: 10.1038/s41577-021-00550-x
发表时间: 2021-06
期刊: Nature reviews. Immunology
影响因子: --
作者:
Cromer D;Juno JA;Khoury D;Reynaldi A;Wheatley AK;Kent SJ;Davenport MP
通讯作者: Davenport MP
DOI: 10.1038/scientificamerican0584-138
发表时间: 1984-01-01
影响因子: 3
作者:
CLIFF, A;HAGGETT, P
通讯作者: HAGGETT, P
DOI: 10.1093/infdis/jiaa392
发表时间: 2021-02-01
影响因子: 6.4
作者:
Galanti, Marta;Shaman, Jeffrey
通讯作者: Shaman, Jeffrey
在未来5年中,免疫生活史,疫苗接种和SARS-COV-2的动态。
DOI: 10.1126/science.abd7343
发表时间: 2020-11-13
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Saad-Roy CM;Wagner CE;Baker RE;Morris SE;Farrar J;Graham AL;Levin SA;Mina MJ;Metcalf CJE;Grenfell BT
通讯作者: Grenfell BT